These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27503607)

  • 21. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.
    Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB
    Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced in vitro antitumor efficacy of a polyunsaturated fatty acid-conjugated pH-responsive self-assembled ion-pairing liposome-encapsulated prodrug.
    Wang Y; Fan P; Zhu L; Zhuang W; Jiang L; Zhang H; Huang H
    Nanotechnology; 2020 Apr; 31(15):155101. PubMed ID: 31846941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer Brush Decorated MOF Nanoparticles Loaded with AIEgen, Anticancer Drug, and Supramolecular Glue for Regulating and In Situ Observing DOX Release.
    Chen S; Chen Q; Dong S; Ma J; Yang YW; Chen L; Gao H
    Macromol Biosci; 2018 Dec; 18(12):e1800317. PubMed ID: 30334359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
    Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
    Chen Z; Zhang P; Cheetham AG; Moon JH; Moxley JW; Lin YA; Cui H
    J Control Release; 2014 Oct; 191():123-30. PubMed ID: 24892976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cascade enzymatic reaction activatable gemcitabine prodrug with an AIE-based intracellular light-up apoptotic probe for in situ self-therapeutic monitoring.
    Han H; Teng W; Chen T; Zhao J; Jin Q; Qin Z; Ji J
    Chem Commun (Camb); 2017 Aug; 53(66):9214-9217. PubMed ID: 28766646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
    Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
    Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid-Liable Cleavage of Doxorubicin@Plunoric-Carbon Dots in Multiplexed Bioimaging and Drug Delivery.
    Priyadarshini E; Rajamani P
    AAPS PharmSciTech; 2020 Nov; 21(8):322. PubMed ID: 33200276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.
    Garsky VM; Lumma PK; Feng DM; Wai J; Ramjit HG; Sardana MK; Oliff A; Jones RE; DeFeo-Jones D; Freidinger RM
    J Med Chem; 2001 Nov; 44(24):4216-24. PubMed ID: 11708923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer.
    Li Y; Yan T; Chang W; Cao C; Deng D
    Biomater Sci; 2019 Aug; 7(9):3652-3661. PubMed ID: 31169833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIE/FRET-based versatile PEG-Pep-TPE/DOX nanoparticles for cancer therapy and real-time drug release monitoring.
    Wang TT; Wei QC; Zhang ZT; Lin MT; Chen JJ; Zhou Y; Guo NN; Zhong XC; Xu WH; Liu ZX; Han M; Gao JQ
    Biomater Sci; 2020 Jan; 8(1):118-124. PubMed ID: 31777865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Covalent Loading of Anti-Cancer Doxorubicin by Modularizable Peptide Self-Assemblies for a Nanoscale Drug Carrier.
    Tomizaki KY; Kishioka K; Kataoka S; Miyatani M; Ikeda T; Komada M; Imai T; Usui K
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29113134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brush-like Polymer Prodrug with Aggregation-Induced Emission Features for Precise Intracellular Drug Tracking.
    Naghibi S; Sabouri S; Hong Y; Jia Z; Tang Y
    Biosensors (Basel); 2022 May; 12(6):. PubMed ID: 35735521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
    Shi NQ; Gao W; Xiang B; Qi XR
    Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorogenic approach to evaluating prodrug hydrolysis and stability in live cells.
    Chen X; Xu Y; Li X; Liao S
    Bioorg Med Chem; 2019 Mar; 27(5):851-858. PubMed ID: 30723042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
    Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z
    Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
    Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
    Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.